OSU, Moffitt Cancer Center Collaborate on Precision Medicine Resource | GenomeWeb

NEW YORK (GenomeWeb) – Ohio State University's cancer institute and the Moffitt Cancer Center have launched a collaboration that will use data and samples from more than 100,000 patients to create a new resource to connect patients and physicians with precision medicine researchers.

Moffitt will team with The OSU Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) to form the Oncology Research Information Exchange Network (ORIEN), the partners said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.